How to buy Medical Developments International shares
Own Medical Developments International shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Medical Developments International Limited is a drug manufacturers-specialty & generic business based in Australia. Medical Developments International shares (MVP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Medical Developments International has a trailing 12-month revenue of around $24.2 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Medical Developments International
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Medical Developments International . Find the share by name or ticker symbol: MVP. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Medical Developments International reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Medical Developments International . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Medical Developments International key stats
- Compare share trading platforms
- Is Medical Developments International stock a buy or sell?
- Medical Developments International performance over time
- Medical Developments International 's financials
- How volatile are Medical Developments International shares?
- Does Medical Developments International pay a dividend?
- Other common questions
Medical Developments International share priceUse our graph to track the performance of MVP stocks over time.
Medical Developments International shares at a glance
|52-week range||$4.57 - $8.32|
|50-day moving average||$5.1537|
|200-day moving average||$5.9207|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.006|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Medical Developments International stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Medical Developments International price performance over time
|1 week (2021-06-17)||-0.21%|
|1 month (2021-05-24)||-3.76%|
|3 months (2021-03-24)||-10.50%|
|6 months (2020-12-24)||-27.57%|
|1 year (2020-06-24)||-36.64%|
|2 years (2019-06-24)||-8.13%|
|3 years (2018-06-22)||-17.63%|
|5 years (2016-06-24)||-19.00%|
Is Medical Developments International under- or over-valued?
Valuing Medical Developments International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medical Developments International 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medical Developments International 's EBITDA
Medical Developments International 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.6 million.
The EBITDA is a measure of a Medical Developments International 's overall financial performance and is widely used to measure a its profitability.
Medical Developments International financials
|Revenue TTM||$24.2 million|
|Operating margin TTM||4.46%|
|Gross profit TTM||$15 million|
|Return on assets TTM||0.71%|
|Return on equity TTM||-1.79%|
|Market capitalisation||$347.1 million|
TTM: trailing 12 months
Medical Developments International share dividends
We're not expecting Medical Developments International to pay a dividend over the next 12 months.
Medical Developments International share price volatility
Over the last 12 months, Medical Developments International 's shares have ranged in value from as little as $4.57 up to $8.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Medical Developments International 's is 1.3472. This would suggest that Medical Developments International 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Medical Developments International overview
Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in home or in hospitals; Penthrox, a prescription only medicine for pain relief; medical devices; and various veterinary anesthetic machines to veterinarians. The company operates in Australia, New Zealand, the United Kingdom, rest of Europe, Canada, the Middle East, Asia, South Africa, North America, and internationally. Medical Developments International Limited was incorporated in 2003 and is headquartered in Scoresby, Australia.
Frequently asked questions
More guides on Finder
Today’s ASX top stocks: Milton Corporation (MLT ↑16.0%), Oneview Healthcare (ONE ↑12.8%)
The 10 biggest movers on the ASX for Tuesday 22 June 2021.
Mobile plans are now more expensive, but here’s a hack to save $200 a year
Telstra, Optus, and Vodafone keep raising their prices even as the rest of the market is more affordable than ever.
Prime Day VR gaming deal: $60 off the Oculus Quest 2
Amazon is selling the standalone Oculus Quest 2 virtual-reality headset for $432.12. You can also score $77 off the 256GB version.
Barefoot Investor: How to watch Scott Pape’s Money Movement docu-series online
This fresh docu-series features the one and only Barefoot Investor.
Prime Day’s best health and fitness deals: Garmin, FitBit, PranaOn
Stocking up on your favourite supplements or adding to your home gym, Amazon has got you covered with these red-hot offers.
Amazon Prime Day’s best camera deals: Nikon, Panasonic and more
DSLR, digital, polaroids, lenses and accessories - these are the best camera deals Amazon has to offer this Prime Day.
Biggest Amazon Prime Day discounts: 75% off games + heaps more
Top offers so far include 75% off games, 68% off tech and 38% off alcohol.
Jetstar sale offers new route to “Australia’s most beautiful coastlines”
You have to be quick, these fares are gone with the strike of midnight.
Kobo Elipsa review: An ereader and enote 2-in-1
The Kobo Elipsa makes a valiant attempt to bridge the gap between eReader and eNote. It doesn’t manage to excel at being one or the other as its big for an eReader, and slow for an eNote.
Ask an Expert